Advertisement

Genome-Wide Association Studies of Hypertension: Have They Been Fruitful?

  • Sajjad Rafiq
  • Sonia Anand
  • Robert RobertsEmail author
Article

Abstract

Over the last two decades candidate gene association studies and genome-wide linkage scans have met with little success in characterizing risk variants for hypertension. Several factors could be responsible for the relative lack of success, although our understanding of the genetics has evolved to support the belief that there are multiple common risk variants, which are associated with hypertension with modest effect sizes. Genome-wide association studies (GWAS) have successfully identified risk loci for several complex polygenic disease states. Until recently, the productivity of GWAS with respect to identifying risk loci for hypertension was limited. In this paper we describe the recent success of GWAS of hypertension in identifying over a dozen loci associated with essential hypertension. We will review these findings, and place these results in the context of the future potential of pharmocogenetics of hypertension.

Keywords

Genome-Wide Association Study Hypertension Genetics Blood Pressure 

References

  1. 1.
    Benjamin, E. J., et al. (1994). Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Journal of the American Medical Association, 271(11), 840–844.CrossRefPubMedGoogle Scholar
  2. 2.
    Kannel, W. B., et al. (1972). Role of blood pressure in the development of congestive heart failure. The Framingham study. New England Journal of Medicine, 287(16), 781–787.PubMedCrossRefGoogle Scholar
  3. 3.
    MacMahon, S., et al. (1990). Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet, 335(8692), 765–774.CrossRefPubMedGoogle Scholar
  4. 4.
    Lifton, R. P., Gharavi, A. G., & Geller, D. S. (2001). Molecular mechanisms of human hypertension. Cell, 104(4), 545–556.CrossRefPubMedGoogle Scholar
  5. 5.
    Newton-Cheh, C., et al. (2009). Genome-wide association study identifies eight loci associated with blood pressure. Nature Genetics.Google Scholar
  6. 6.
    Levy, D., et al. (2009). Genome-wide association study of blood pressure and hypertension. Nature Genetics.Google Scholar
  7. 7.
    Pickering, T. G. (1994). Blood pressure measurement and detection of hypertension. Lancet, 344(8914), 31–35.CrossRefPubMedGoogle Scholar
  8. 8.
    Fagard, R. H., et al. (2000). Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation, 102(10), 1139–1144.PubMedGoogle Scholar
  9. 9.
    Staessen, J. A., et al. (2003). Essential hypertension. Lancet, 361(9369), 1629–1641.CrossRefPubMedGoogle Scholar
  10. 10.
    Harrap, S. B. (1994). Hypertension: genes versus environment. Lancet, 344(8916), 169–171.CrossRefPubMedGoogle Scholar
  11. 11.
    Levy, D., et al. (2000). Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham heart study. Hypertension, 36(4), 477–483.PubMedGoogle Scholar
  12. 12.
    Fuentes, R. M., et al. (2000). Familial aggregation of blood pressure: a population-based family study in eastern Finland. Journal of Human Hypertension, 14(7), 441–445.CrossRefPubMedGoogle Scholar
  13. 13.
    Hong, Y., et al. (1997). Genetic and environmental architecture of the features of the insulin-resistance syndrome. American Journal of Human Genetics, 60(1), 143–152.PubMedGoogle Scholar
  14. 14.
    Luft, F. C. (2001). Twins in cardiovascular genetic research. Hypertension, 37(2 Part 2), 350–356.PubMedGoogle Scholar
  15. 15.
    Scherrer, J. F., et al. (2003). A twin study of depression symptoms, hypertension, and heart disease in middle-aged men. Psychosomatic Medicine, 65(4), 548–557.CrossRefPubMedGoogle Scholar
  16. 16.
    Feinleib, M., et al. (1977). The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. American Journal of Epidemiology, 106(4), 284–285.PubMedGoogle Scholar
  17. 17.
    Hunt, S. C., et al. (1989). Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. American Journal of Epidemiology, 129(3), 625–638.PubMedGoogle Scholar
  18. 18.
    Slattery, M. L., et al. (1988). Lifestyle and blood pressure levels in male twins in Utah. Genetic Epidemiology, 5(4), 277–287.CrossRefPubMedGoogle Scholar
  19. 19.
    Williams, P. D., et al. (1992). Platelet cytosolic free calcium concentration, total plasma calcium concentration and blood pressure in human twins: a genetic analysis. Clinical Science (London, England), 82(5), 493–504.Google Scholar
  20. 20.
    Williams, P. D., et al. (1993). Genetic and environmental covariance of serum cholesterol and blood pressure in female twins. Atherosclerosis, 100(1), 19–31.CrossRefPubMedGoogle Scholar
  21. 21.
    Fagard, R., et al. (1995). Heritability of conventional and ambulatory blood pressures. A study in twins. Hypertension, 26(6 Pt 1), 919–924.PubMedGoogle Scholar
  22. 22.
    Somes, G. W., et al. (1995). Genetic influences on ambulatory blood pressure patterns. The Medical College of Virginia Twin Study. American Journal of Hypertension, 8(5 Pt 1), 474–478.CrossRefPubMedGoogle Scholar
  23. 23.
    Dyer, A. R., & Elliott, P. (1989). The INTERSALT study: relations of body mass index to blood pressure. INTERSALT Co-operative Research Group. Journal of Human Hypertension, 3(5), 299–308.PubMedGoogle Scholar
  24. 24.
    Midgley, J. P., et al. (1996). Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. Journal of the American Medical Association, 275(20), 1590–1597.CrossRefPubMedGoogle Scholar
  25. 25.
    Wareham, N. J., et al. (2000). Quantifying the association between habitual energy expenditure and blood pressure. International Journal of Epidemiology, 29(4), 655–660.CrossRefPubMedGoogle Scholar
  26. 26.
    Wilk, J. B., et al. (2004). Genome-wide linkage analyses for age at diagnosis of hypertension and early-onset hypertension in the HyperGEN study. American Journal of Hypertension, 17(9), 839–844.CrossRefPubMedGoogle Scholar
  27. 27.
    Arnett, D. K., et al. (2007). Relevance of genetics and genomics for prevention and treatment of cardiovascular disease: a scientific statement from the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation, 115(22), 2878–2901.CrossRefPubMedGoogle Scholar
  28. 28.
    Cusi, D., et al. (1997). Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet, 349(9062), 1353–1357.CrossRefPubMedGoogle Scholar
  29. 29.
    Ji, W., et al. (2008). Rare independent mutations in renal salt handling genes contribute to blood pressure variation. Nature Genetics, 40(5), 592–599.CrossRefPubMedGoogle Scholar
  30. 30.
    Tobin, M. D., et al. (2008). Common variants in genes underlying monogenic hypertension and hypotension and blood pressure in the general population. Hypertension, 51(6), 1658–1664.CrossRefPubMedGoogle Scholar
  31. 31.
    Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14, 000 cases of seven common disease and 3, 000 shared controls. Nature, 447(7145), 661–668.CrossRefGoogle Scholar
  32. 32.
    Lifton, R. P. (1996). Molecular genetics of human blood pressure variation. Science, 272(5262), 676–680.CrossRefPubMedGoogle Scholar
  33. 33.
    Sober, S., et al. (2009). Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PLoS ONE, 4(6), e6034.CrossRefPubMedGoogle Scholar
  34. 34.
    Pare, G., et al. (2007). Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. American Journal of Human Genetics, 80(4), 673–682.CrossRefPubMedGoogle Scholar
  35. 35.
    Morgan, T. M., et al. (2007). Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. Journal of the American Medical Association, 297(14), 1551–1561.CrossRefPubMedGoogle Scholar
  36. 36.
    Barrett, J. C., & Cardon, L. R. (2006). Evaluating coverage of genome-wide association studies. Nature Genetics, 38(6), 659–662.CrossRefPubMedGoogle Scholar
  37. 37.
    Padmanabhan, S., et al. (2008). Hypertension and genome-wide association studies: combining high fidelity phenotyping and hypercontrols. Journal of Hypertension, 26(7), 1275–1281.CrossRefPubMedGoogle Scholar
  38. 38.
    Sabatti, C., et al. (2009). Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Nature Genetics, 41(1), 35–46.CrossRefPubMedGoogle Scholar
  39. 39.
    Wang, Y., et al. (2009). From the cover: whole-genome association study identifies STK39 as a hypertension susceptibility gene. Proceedings of the National Academy of Sciences of the United States of America, 106(1), 226–231.CrossRefPubMedGoogle Scholar
  40. 40.
    Org, E., et al. (2009). Genome-wide scan identifies CDH13 as a novel susceptibility locus contributing to blood pressure determination in two European populations. Human Molecular Genetics, 18(12), 2288–2296.CrossRefPubMedGoogle Scholar
  41. 41.
    Arnett, D. K., Claas, S. A., & Glasser, S. P. (2006). Pharmacogenetics of antihypertensive treatment. Vascular Pharmacology, 44(2), 107–118.CrossRefPubMedGoogle Scholar
  42. 42.
    Arnett, D. K., et al. (2005). Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study. Circulation, 111(25), 3374–3383.CrossRefPubMedGoogle Scholar
  43. 43.
    Filigheddu, F., et al. (2008). Clinical variables, not RAAS polymorphisms, predict blood pressure response to ACE inhibitors in Sardinians. Pharmacogenomics, 9(10), 1419–1427.CrossRefPubMedGoogle Scholar
  44. 44.
    Psaty, B. M., et al. (2002). Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. Journal of the American Medical Association, 287(13), 1680–1689.CrossRefPubMedGoogle Scholar
  45. 45.
    van Wieren-de Wijer, D. B., et al. (2009). Interaction between the Gly460Trp alpha-adducin gene variant and diuretics on the risk of myocardial infarction. Journal of Hypertension, 27(1), 61–68.CrossRefPubMedGoogle Scholar
  46. 46.
    Lynch, A. I., et al. (2008). Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. Journal of the American Medical Association, 299(3), 296–307.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Department of Medicine and Clinical EpidemiologyMcMaster UniversityHamiltonCanada
  2. 2.The John & Jennifer Ruddy Canadian Cardiovascular Genetics CentreUniversity of Ottawa Heart InstituteOttawaCanada

Personalised recommendations